BU-NOT-SET

CONTACT US
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Outsourcing stability testing
  • Analytical chemistry
Eyes
Insight
Brexit: What’s next for UK pharma?
  • Industry trends
Eyes
Insight
Navigating approval filings choppy international waters
  • Drug substance
Eyes
Insight
Regulatory requirements for drug substances
  • Drug substance
Product check
Insight
Insight
  • Drug product
  • Manufacturing
Using blow-fill-seal technology for biologic and vaccine delivery
Webinar
Webinar: Understanding the benefits of blow-fill-seal unidose for ophthalmics, as an alternative to glass vials
Insight
  • Industry trends
  • Manufacturing
A leading global CDMO, renowned for its reliable & on-time offerings
Insight
  • Biologics
Navigating challenges in progressing breakthrough RNA therapeutics
Report
  • Sustainability
Sustainability report 2023
Insight
  • Industry trends
  • Manufacturing
Navigating pre-filled syringe filling complexities
Insight
  • Industry trends
  • Manufacturing
New product introduction: key to getting innovations from pilot to product
Case study
  • Drug product
Tackling antimicrobial resistance
Insight
  • Biologics
A new centre for continuous mRNA manufacturing